Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc., headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in advanced DNA synthesis and genomic technologies. Founded in 2018, the company has rapidly established itself as a leader in synthetic biology, focusing on innovative solutions for research and therapeutic applications. Ansa Biotechnologies offers unique, high-fidelity DNA synthesis services that cater to a diverse range of sectors, including pharmaceuticals, agriculture, and environmental science. Their proprietary technology enables rapid and cost-effective production of custom DNA sequences, setting them apart in a competitive market. With a commitment to quality and precision, Ansa Biotechnologies has achieved significant milestones, positioning itself as a trusted partner for researchers and companies seeking cutting-edge biotechnological solutions.
DitchCarbon Score
How does Ansa Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ansa Biotechnologies, Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ansa Biotechnologies, Inc.'s reported carbon emissions
Ansa Biotechnologies, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their current impact on climate change or their commitment to sustainability. However, the absence of data may indicate an opportunity for the company to enhance transparency and set measurable climate goals in line with industry standards. As the biotechnology sector increasingly prioritises environmental responsibility, Ansa Biotechnologies may benefit from establishing clear emissions reduction targets and engaging in climate pledges to align with global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ansa Biotechnologies, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
